{"id":"https://openalex.org/W4310108996","doi":"https://doi.org/10.1182/blood-2022-168303","title":"Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3-Mutated Acute Myeloid Leukemia (AML)","display_name":"Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3-Mutated Acute Myeloid Leukemia (AML)","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310108996","doi":"https://doi.org/10.1182/blood-2022-168303"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-168303","doi":"https://doi.org/10.1182/blood-2022-168303","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-168303","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004970562","display_name":"Ahmad Ghorab","orcid":"https://orcid.org/0000-0003-3429-2737","observed_orcids":["https://orcid.org/0000-0003-3429-2737"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmad Ghorab","raw_affiliation_strings":["1Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085360755","display_name":"Mark Robert Litzow","orcid":"https://orcid.org/0000-0002-9816-6302","observed_orcids":["https://orcid.org/0000-0002-9816-6302"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark R. Litzow","raw_affiliation_strings":["2Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002643270","display_name":"Naseema Gangat","orcid":"https://orcid.org/0000-0002-9104-6172","observed_orcids":["https://orcid.org/0000-0002-9104-6172"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naseema Gangat","raw_affiliation_strings":["2Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008422091","display_name":"Aref Al\u2010Kali","orcid":"https://orcid.org/0000-0002-0824-3715","observed_orcids":["https://orcid.org/0000-0002-0824-3715"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aref Al-Kali","raw_affiliation_strings":["2Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020872528","display_name":"Mithun Vinod Shah","orcid":"https://orcid.org/0000-0002-5359-336X","observed_orcids":["https://orcid.org/0000-0002-5359-336X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mithun V. Shah","raw_affiliation_strings":["2Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023628069","display_name":"Hemant S. Murthy","orcid":"https://orcid.org/0000-0003-4534-4248","observed_orcids":["https://orcid.org/0000-0003-4534-4248"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hemant S. Murthy","raw_affiliation_strings":["1Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016216479","display_name":"Ayalew Tefferi","orcid":"https://orcid.org/0000-0003-4605-3821","observed_orcids":["https://orcid.org/0000-0003-4605-3821"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ayalew Tefferi","raw_affiliation_strings":["2Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064856519","display_name":"Hassan B. Alkhateeb","orcid":"https://orcid.org/0000-0002-3609-8404","observed_orcids":["https://orcid.org/0000-0002-3609-8404"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hassan B. Alkhateeb","raw_affiliation_strings":["2Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080965667","display_name":"Kebede H. Begna","orcid":"https://orcid.org/0000-0003-2730-8593","observed_orcids":["https://orcid.org/0000-0003-2730-8593"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kebede Begna","raw_affiliation_strings":["3Divison of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Divison of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072463255","display_name":"Mrinal M. Patnaik","orcid":"https://orcid.org/0000-0001-6998-662X","observed_orcids":["https://orcid.org/0000-0001-6998-662X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mrinal M. Patnaik","raw_affiliation_strings":["2Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035051206","display_name":"James M. Foran","orcid":"https://orcid.org/0000-0003-1673-1708","observed_orcids":["https://orcid.org/0000-0003-1673-1708"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James M. Foran","raw_affiliation_strings":["1Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079157559","display_name":"Talha Badar","orcid":"https://orcid.org/0000-0003-1548-918X","observed_orcids":["https://orcid.org/0000-0003-1548-918X"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Talha Badar","raw_affiliation_strings":["4Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL","institution_ids":["https://openalex.org/I4210146710"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.1858,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.51635922,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"9019","last_page":"9020"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.8840000033378601},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.9660000205039978},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8840000033378601},{"id":"https://openalex.org/keywords/flt3-mutation","display_name":"FLT3 mutation","score":0.9710000157356262},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.6759999990463257},{"id":"https://openalex.org/keywords/unfit-patients","display_name":"unfit patients","score":0.9179999828338623},{"id":"https://openalex.org/keywords/induction-therapy","display_name":"induction therapy","score":0.7319999933242798},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.9700000286102295},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":1.0},{"id":"https://openalex.org/keywords/flt3-inhibitors","display_name":"FLT3 inhibitors","score":0.5929999947547913},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.4740000069141388},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.6460000276565552},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.46399998664855957},{"id":"https://openalex.org/keywords/secondary-acute-myeloid-leukemia","display_name":"secondary acute myeloid leukemia","score":0.621999979019165},{"id":"https://openalex.org/keywords/cytogenetics","display_name":"cytogenetics","score":0.531000018119812},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.6230000257492065},{"id":"https://openalex.org/keywords/flt3-tkd","display_name":"FLT3-TKD","score":0.8799999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8429495096206665},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.8063598871231079},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.7605631351470947},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.7376659512519836},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7126754522323608},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.6139422655105591},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5712932348251343},{"id":"https://openalex.org/C2776611710","wikidata":"https://www.wikidata.org/wiki/Q16888295","display_name":"Induction chemotherapy","level":3,"score":0.5660829544067383},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4767264425754547},{"id":"https://openalex.org/C9583187","wikidata":"https://www.wikidata.org/wiki/Q7919510","display_name":"Ven","level":2,"score":0.4602765738964081},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.44966450333595276},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.42017924785614014},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.41211026906967163},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.40982338786125183},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4021832346916199},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3959030508995056},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33527156710624695},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.12159830331802368},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-168303","doi":"https://doi.org/10.1182/blood-2022-168303","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-168303","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7214458355","https://openalex.org/W3040121048","https://openalex.org/W3211430792","https://openalex.org/W4296468270","https://openalex.org/W3095251964","https://openalex.org/W4386282029","https://openalex.org/W3094662635","https://openalex.org/W4386605219","https://openalex.org/W7203787138","https://openalex.org/W4225262626"],"abstract_inverted_index":{"Introduction:":[0],"FMS-like":[1],"tyrosine":[2],"kinase":[3],"3":[4],"(FLT3)":[5],"mutation":[6,275,496],"(m)":[7],"is":[8,22,46,59],"one":[9,144,387],"of":[10,28,37,70,146,188,202,210,244,313,328,337,378,406,418,426],"the":[11,67,132,171,189,211,245,314,329,338,369,375,407,437,468],"most":[12],"prevalent":[13],"mutations":[14,291,300],"in":[15,184,451,528,540,559],"acute":[16],"myeloid":[17],"leukemia":[18],"(AML),":[19],"and":[20,30,80,106,116,124,234,253,266,273,303,308,334,398,436,462,476,515,568],"it":[21],"associated":[23,482,525],"with":[24,49,82,198,231,240,319,365,412,483,526,561],"an":[25],"increased":[26],"risk":[27,478],"relapse":[29,411,417,465],"decreased":[31],"overall":[32],"survival":[33],"(OS).":[34],"The":[35,179,278,346,423],"standard":[36],"care":[38],"therapy":[39,364,402,461,575],"for":[40,77,103,121,131,372,464,471,549,569],"physically":[41],"fit":[42],"treatment":[43,125,541],"na\u00efve":[44,542],"patients":[45,73,99,140,190,212,221,226,236,246,256,269,315,330,339,359,409,453,545],"intensive":[47,78,104,550],"chemotherapy":[48,79,105],"FLT3":[50,271,562],"inhibitor":[51,563],"(i)":[52],"(midostaurin).":[53],"For":[54],"older/unfit":[55],"patients,":[56],"venetoclax-based":[57],"induction":[58,91,109],"preferred":[60],"as":[61,459,556,577],"per":[62],"NCCN":[63],"guidelines.":[64],"We":[65],"explored":[66],"clinical":[68,122],"outcome":[69,566],"FLT3m":[71,97,281,500,543],"AML":[72,98,230,488,544],"who":[74,100,128,546],"were":[75,101,119,137,167,193,238,294,481,522,547],"ineligible":[76,102,548],"treated":[81],"a":[83,199,413,557],"hypomethylating":[84],"agent":[85],"(HMA)":[86],"plus":[87],"venetoclax":[88],"(Ven)":[89],"based":[90],"at":[92,110,142,262,497,509],"Mayo":[93,111],"Clinic.":[94],"Methods:":[95],"Thirty":[96],"received":[107,129,141,381,389,399,450,458],"HMA+Ven":[108,130,344,370,379,552],"Clinic":[112],"between":[113],"June":[114],"2019":[115],"May":[117],"2022":[118,172],"analyzed":[120],"characteristics":[123,181],"outcomes.":[126],"Patients":[127],"relapsed":[133],"or":[134,157,320,506],"refractory":[135,341],"disease":[136,342],"excluded.":[138],"All":[139],"least":[143],"cycle":[145],"HMA,":[147],"either":[148],"azacitidine":[149],"(75":[150],"mg/m2":[151,160],"from":[152,161],"day":[153,162],"1":[154,163],"to":[155,164,170,207,343,349,416,564,572],"7)":[156],"decitabine":[158],"(20":[159],"5).":[165],"Responses":[166],"assessed":[168],"according":[169],"European":[173],"Leukemia":[174],"Net":[175],"(ELN)":[176],"criteria.":[177],"Results:":[178],"baseline":[180,280],"are":[182],"summarized":[183],"Table":[185],"1.":[186],"Most":[187,288,357],"(n=27,":[191],"90%)":[192],"\u2265":[194],"65":[195],"years":[196,204],"old":[197],"median":[200,279,347,376,414,424,438],"age":[201],"74":[203],"(range,":[205,286,355,384,421],"59":[206],"88).":[208],"Majority":[209],"(n=16,":[213],"53%)":[214],"had":[215,222,228,249,257,270,331,340,410],"de":[216],"novo":[217,491],"AML,":[218,224],"8":[219],"(27%)":[220],"secondary":[223],"4":[225,267],"(13%)":[227,268],"primary":[229],"MDS-related":[232],"changes,":[233],"2":[235],"(7%)":[237],"diagnosed":[239],"therapy-related":[241],"AML.":[242],"Two-thirds":[243],"(n=20,":[247],"67%)":[248],"diploid":[250,473],"cytogenetics":[251,474,479],"(CG)":[252,260],"10":[254],"(33%)":[255],"additional":[258],"cytogenetic":[259],"abnormality":[261],"diagnosis.":[263],"Twenty-six":[264],"(87%)":[265],"ITD":[272],"TKD":[274],"subtypes,":[276],"respectively.":[277],"allelic":[282,507],"ratio":[283,508],"was":[284,352,382,428,440,449],"0.39":[285],"0.1-0.7).":[287],"frequent":[289],"reported":[290],"(\u2265":[292],"5%)":[293],"DNMT3A":[295],"(40%),":[296],"NPM1":[297,495],"(37%),":[298],"spliceosome":[299],"(SF3B1,":[301],"U2AF1,":[302],"SRSF2;":[304],"30%),":[305],"RUNX1":[306],"(23%),":[307],"TET2":[309],"(17%).":[310],"Seventy":[311],"percent":[312],"achieved":[316],"complete":[317],"remission":[318,397],"without":[321],"count":[322],"recovery":[323],"(CR/CRi)":[324],"(n=21),":[325],"13%":[326],"(n=4)":[327],"partial":[332],"remission,":[333],"17%":[335],"(n=5)":[336],"induction.":[345],"time":[348,415],"achieve":[350],"CR/CRi":[351,358,408],"35":[353],"days":[354],"22-230).":[356],"(86%,":[360],"n=18)":[361],"continued":[362],"consolidation":[363],"HMA+Ven.":[366],"Until":[367],"changing":[368],"regimen":[371],"any":[373],"reason,":[374],"number":[377],"cycles":[380],"6":[383,419,452],"1-13).":[385],"Only":[386],"patient":[388],"allogeneic":[390],"stem":[391],"cell":[392],"transplant":[393],"allo-HSCT":[394],"after":[395],"achieving":[396],"gilteritinib":[400],"maintenance":[401,460],"post-transplant.":[403],"Six":[404],"(29%)":[405],"months":[420,430,442],"1-10).":[422],"duration":[425],"response":[427],"13":[429],"(95%":[431,443],"CI:":[432,444],"6.71-19.28)":[433],"(Figure":[434],"1A),":[435],"OS":[439,486,529],"15":[441],"8.89-21.10)":[445],"(Figure-1B).":[446],"FLT3i":[447],"(gilteritinib)":[448],"(20%)":[454],"post":[455],"HMA+Ven;":[456],"2/6":[457],"4/6":[463],"disease.":[466],"In":[467,533],"univariate":[469],"analysis":[470],"OS,":[472],"(p<0.0001)":[475],"non-high":[477],"(p=0.04)":[480],"significantly":[484,524],"better":[485],"(Figure-1D/E).":[487],"sub-type":[489,517],"(de":[490],"vs":[492,503,512,519],"sAML)":[493],"(p=0.97),":[494],"diagnosis":[498,510],"(p=0.39),":[499],"subtype":[501],"(ITD":[502],"TKD)":[504],"(p=0.79)":[505],"(<0.5":[511],">0.5)":[513],"(p=0.89),":[514],"HMA":[516],"(azacitidine":[518],"decitabine)":[520],"(p=0.43)":[521],"not":[523],"difference":[527],"(Figure-1C/F/G/H,":[530],"respectively).":[531],"Conclusions:":[532],"summary,":[534],"HMA+":[535],"Ven":[536],"showed":[537],"significant":[538],"activity":[539],"chemotherapy.":[551],"can":[553],"be":[554],"used":[555],"backbone":[558],"combination":[560],"improve":[565],"further":[567],"successful":[570],"transition":[571],"curative":[573],"intent":[574],"such":[576],"allo-HSCT.":[578],"Figure":[579],"1View":[580,583],"largeDownload":[581,584],"PPTFigure":[582],"PPT":[585],"Close":[586],"modal":[587]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-11-30T00:00:00"}